MDCE Highlights StrainScan Pro's Enterprise-Ready Agricultural AI Tech Optimized for Rapid Multi-Location Rollout on iPad Air (OTC PINK:MDCE)

Rhea-AI Summary

Medical Care Technologies (OTC PINK:MDCE) highlighted the enterprise-ready design of its StrainScan Pro AI vision platform, which uses a proprietary architecture optimized for rapid, straightforward deployment across multi-location retail and agricultural operations on iPad Air devices.

According to Medical Care Technologies, this tablet-based approach is intended to lower adoption barriers versus fixed industrial systems by standardizing the same software across fields, packing facilities, distribution environments, and retail sites. The company emphasized that it develops and commercializes AI vision software but does not cultivate, process, distribute, or sell cannabis or any plant products, and continues to generate revenue through operating subsidiaries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Proprietary AI Vision Platform Designed for Simple, Scalable Deployment Across Multi-Site Retail and Agricultural Operations

MESA, AZ / ACCESS Newswire / August 25, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today emphasized the enterprise-ready design of its StrainScan Pro platform, highlighting a proprietary AI vision architecture built for rapid and straightforward deployment across multi-location environments.

StrainScan Pro is optimized for installation on iPad Air devices, enabling operators to implement advanced visual analysis without the cost or complexity of fixed industrial systems. This approach supports fast rollout across single sites or large multi-location networks, whether in regulated retail settings or agricultural operations.

By focusing on deployment simplicity, the platform is positioned to reduce barriers to adoption for enterprise clients who need consistent visual tools at scale. Operators can place the same proprietary software in the field, at packing facilities, in distribution environments, or across retail locations using a uniform, portable form factor.

"Enterprise value is not only about capability - it is also about how quickly and cleanly a solution can be put to work," said Marshall Perkins, CEO of Medical Care Technologies. "StrainScan Pro is designed for rapid multi-location deployment on iPad Air. That simplicity is intentional. We want operators to be able to scale visual intelligence without building complex infrastructure."

Medical Care Technologies is a technology company. It develops and commercializes AI vision software and does not cultivate, process, distribute, or sell cannabis or any plant products.

As multi-location operators in both retail and agriculture continue to seek practical ways to standardize quality verification, the combination of proprietary AI performance and easy enterprise deployment remains a central focus of the StrainScan Pro platform.

Investors and industry participants can explore the platform at:
https://strainscanpro.com

Medical Care Technologies continues to advance its AI vision capabilities across high-value verticals while generating revenue through its operating subsidiaries.

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC PINK:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. Visit: https://medicalcaretechnologies.com

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.

Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: marshall@medicalcaretechnologies.com
Websites: https://medicalcaretechnologies.com | https://strainscanpro.com

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

FAQ

What is StrainScan Pro from Medical Care Technologies (OTC PINK:MDCE)?

StrainScan Pro is a proprietary AI vision software platform designed for enterprise use, according to Medical Care Technologies. It focuses on visual analysis and quality verification across multi-location retail and agricultural operations, using a consistent software system that can be deployed in fields, packing, distribution, and retail environments.

How is StrainScan Pro deployed on iPad Air for MDCE customers?

StrainScan Pro is optimized specifically for deployment on iPad Air devices, according to Medical Care Technologies. This portable form factor is intended to replace more complex fixed industrial systems, enabling faster rollout and easier scaling of visual intelligence tools across multiple locations within retail and agricultural networks.

Which industries does StrainScan Pro target for enterprise rollout as of August 25, 2026?

According to Medical Care Technologies, StrainScan Pro targets multi-location operators in regulated retail environments and agricultural operations. The platform is positioned to support standardized quality verification using AI vision across fields, packing facilities, distribution centers, and retail locations, focusing on simple, scalable deployment for enterprise clients.

Does Medical Care Technologies (MDCE) handle cannabis products with StrainScan Pro?

Medical Care Technologies states it develops and commercializes AI vision software only. The company clarifies it does not cultivate, process, distribute, or sell cannabis or any plant products, positioning StrainScan Pro as a software solution rather than a provider of agricultural or cannabis-related goods.

How does StrainScan Pro aim to reduce deployment barriers for MDCE enterprise clients?

According to Medical Care Technologies, StrainScan Pro emphasizes deployment simplicity and uniform hardware via iPad Air. This design is intended to help enterprises scale consistent visual tools quickly across multiple locations without building complex infrastructure, supporting standardized quality verification in both retail and agricultural settings.

How does Medical Care Technologies (OTC PINK:MDCE) generate revenue around StrainScan Pro?

Medical Care Technologies reports it generates revenue through its operating subsidiaries while advancing AI vision capabilities like StrainScan Pro. The company focuses on commercializing artificial intelligence-powered applications across health, wellness, nutrition, lifestyle, and enterprise imaging analysis, using these business units as revenue sources.